KPL₹3,528.40-2.48%
83/100
0100 · strongest
strong
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %KPL financial summary
For Mar 2026, Kwality Pharmaceuticals Ltd reported revenue of ₹503 crore, which grew 35.9% from the previous year. Net profit was ₹67 crore, which grew 67.5% year on year, on an operating margin of 24%. Earnings per share came in at ₹64.91. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹503 crore |
|---|---|
| Net profit | ₹67 crore |
| Operating margin | 24% |
| EPS | ₹64.91 |